SSRI use in pregnancy increases PPHN risk by 200%, says new study

Using an SSRI antidepressant drug during pregnancy increases the risk of Primary Pulmonary Hypertension of the Newborn (PPHN) by more than 200%, according to a new study published on January 12, 2012, in the British Medical Journal.

SSRI stands for “Selective Serotonin Reuptake Inhibitor.” This class of antidepressant medications includes Zoloft (sertraline), Prozac (fluoxetine), Paxil (paroxetine), Celexa (citalopram) and Lexapro (escitalopram), among others.

Researchers reviewed records of 1.6 million babies born in 5 European countries between 1996-2007 and found that the risk of PPHN was more than 200% higher for those babies whose mother’s took an SSRI antidepressant in the 2nd half of pregnancy.   This finding bolsters a FDA warning issued in 2006 that alerts women that use of an SSRI after the 20th week of pregnancy increases PPHN risk by 600%.

If you or a loved one took an SSRI antidepressant during pregnancy and your baby had PPHN, you may be entitled to financial compensation. You may have a claim to a SSRI antidepressant drug lawsuit settlement and should talk with a lawyer right away. Contact us now for a free consultation with a top national SSRI antidepressant drug lawsuit attorney to discuss your legal rights. 800-845-6913

PPHN stands for Persistent Pulmonary Hypertension of the Newborn,  a life-threatening condition that develops soon after and infant is born.  Pulmonary means related to the lung. Hypertension means high blood pressure.  The pressure in the blood vessels to the lungs of a baby with PPHN is so high that bloodflow into the lungs is restricted and the amount of oxygen that gets into the bloodstream is limited.   As a result, other organs in the body do not get enough oxygen to function properly.

Newborns with PPHN have breathing problems soon after birth when their circulatory system does not make the normal transition from fetal to newborn circulation.   This condition is known as persistent fetal circulation or PFC.  Common symptoms of PPHN include rapid breathing and heart rate, respiratory distress signs such as flaring nostrils and grunting, and blue coloration of the skin. Approximately 11% of newborns diagnosed with PPHN will suffer death as a result.

Legal Options

Parents and children with PPHN have legal rights. If your child developed Persistent Pulmonary Hypertension of the Newborn (PPHN), you may have legal options to recover financial compensation.  While no amount of money damages can compensate parents for the emotional costs, Zoloft PPHN lawsuit settlements and awards have delivered much needed support to help ease the financial burden on families to provide care for their child.

PPHN Resources

Parents want the best for their children.  Being aware of the resources and options available to you can help you plan for your child’s future.   If your child has been diagnosed with PPHN, contact us today for a free no-obligation conversation about how we can serve your family.  Call us toll-free at 800-845-6913 or submit our online contact request form.

Zoloft use during pregnancy is up despite birth defects risk, says new 2011 drug study

Use of Zoloft during pregnancy increased by about 200% in recent years, despite birth defects risks linked to the SSRI antidepressant drug, according to a 2011 study published by the American Journal of Obstetrics and Gynecology. The study, “Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008,” found that Zoloft (setraline) has become […]

Read More

SSRI study compares birth defects: Zoloft use while pregnant has highest risk of septal heart defects

Researchers in Denmark have found a link between the use of SSRI antidepressants during early pregnancy and an increased risk of congenital heart defects. Among the SSRI antidepressants studied, Zoloft (setraline) was found to have the highest risk of heart defects. Zoloft use during early pregnancy was found to be associated with a threefold increase […]

Read More